CLOREXYDERM
CLOREXYDERM SOL 4% FOAM 100 ML
CLOREXYDERM SOL 4% FOAM 100 ML
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
Clorexyderm
SOLUTION 4%
- Adjuvant to shampoo therapy in the course of deep pyoderma, skin fold dermatitis and dermatophytosis;
- Skin disinfectant with humectant and emollient action;
- Disinfectant for surgical asepsis of the patient and the surgeon;
- Detergent and disinfectant for cleaning otoscopic cones.
Characteristics
1. Clorexyderm 4% Solution has an antimicrobial action (bacteria, dermatophytosis and yeasts) and is not inactivated in the presence of pus and organic material.
2. Propylene glycol provides a humidifying action.
3. Glycerin and lanolin have a humectant and hydrating action.
4. Active against microorganisms sensitive to chlorhexidine.
Components
Chlorhexidine digluconate 4%; propylene glycol; glycerin; lanolin.
Format
100 ml.
Cod. PP1500007
CLOREXYDERM
CLOREXYDERM SOL 4% FOAM 100 ML
CLOREXYDERM SOL 4% FOAM 100 ML
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
